EVOGENE LTD (EVGN) Stock Overview
NASDAQ:EVGN - IL0011050551 - Common Stock
EVGN Key Statistics, Chart & Performance
The current stock price of EVGN is 1.203 USD. In the past month the price decreased by -2.2%. In the past year, price decreased by -59.36%.
EVGN Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 20.07 | 375.50B | ||
| AMGN | AMGEN INC | 13.01 | 152.70B | ||
| GILD | GILEAD SCIENCES INC | 14.86 | 142.76B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 23.38 | 101.56B | ||
| REGN | REGENERON PHARMACEUTICALS | 12.56 | 60.77B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | N/A | 59.25B | ||
| ARGX | ARGENX SE - ADR | 80.99 | 45.95B | ||
| ONC | BEONE MEDICINES LTD-ADR | 5.99 | 40.63B | ||
| INSM | INSMED INC | N/A | 30.67B | ||
| BNTX | BIONTECH SE-ADR | N/A | 27.03B | ||
| NTRA | NATERA INC | N/A | 23.06B | ||
| BIIB | BIOGEN INC | 8.79 | 20.62B |
Related stock screener links
About EVGN
Company Profile
Evogene Ltd. engages in the development and commercialization of a computer-biological platform for improving the development processes of products in the field of life sciences. Leveraging Big Data and Artificial Intelligence while incorporating a deep understanding of biology, Evogene established its technology, the Computational Predictive Biology (CPB) platform, to computationally design microbes, small molecules and genes as the core components for life-science products. Evogene holds a number of subsidiaries utilizing the CPB platform, for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits and ag-solutions for castor oil production.
Company Info
EVOGENE LTD
13 Gad Feinstein Street, Park Rehovot
Rehovot 7414002 IL
CEO: Ofer Haviv
Employees: 117
Phone: 97289311900
EVOGENE LTD / EVGN FAQ
What is the stock price of EVOGENE LTD today?
The current stock price of EVGN is 1.203 USD. The price increased by 0.25% in the last trading session.
What is the ticker symbol for EVOGENE LTD stock?
The exchange symbol of EVOGENE LTD is EVGN and it is listed on the Nasdaq exchange.
On which exchange is EVGN stock listed?
EVGN stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for EVOGENE LTD stock?
8 analysts have analysed EVGN and the average price target is 3.06 USD. This implies a price increase of 154.36% is expected in the next year compared to the current price of 1.203. Check the EVOGENE LTD stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is EVOGENE LTD worth?
EVOGENE LTD (EVGN) has a market capitalization of 10.48M USD. This makes EVGN a Nano Cap stock.
How many employees does EVOGENE LTD have?
EVOGENE LTD (EVGN) currently has 117 employees.
What are the support and resistance levels for EVOGENE LTD (EVGN) stock?
EVOGENE LTD (EVGN) has a support level at 1.2 and a resistance level at 1.26. Check the full technical report for a detailed analysis of EVGN support and resistance levels.
Is EVOGENE LTD (EVGN) expected to grow?
The Revenue of EVOGENE LTD (EVGN) is expected to decline by -45.72% in the next year. Check the estimates tab for more information on the EVGN EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy EVOGENE LTD (EVGN) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of EVGN, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of EVGN, evaluating the profitability, health, valuation and growth aspects
- EVOGENE LTD (EVGN) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- EVOGENE LTD (EVGN) Sales and EPS estimates to see what analysts future expectations are.
- EVOGENE LTD (EVGN) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- EVOGENE LTD (EVGN) Insider and Institutional Ownership to learn about the owners and their transactions.
- EVOGENE LTD (EVGN) Stock Chart to make your own analysis
- EVOGENE LTD (EVGN) Latest news and press-releases to stay up to date.
Does EVOGENE LTD (EVGN) stock pay dividends?
EVGN does not pay a dividend.
When does EVOGENE LTD (EVGN) report earnings?
EVOGENE LTD (EVGN) will report earnings on 2025-11-19, before the market open.
What is the Price/Earnings (PE) ratio of EVOGENE LTD (EVGN)?
EVOGENE LTD (EVGN) does not have a PE ratio as the earnings reported over the last twelve months were negative (-2.25).
What is the Short Interest ratio of EVOGENE LTD (EVGN) stock?
The outstanding short interest for EVOGENE LTD (EVGN) is 1.81% of its float. Check the ownership tab for more information on the EVGN short interest.
EVGN Technical Analysis
EVGN Fundamental Analysis
ChartMill assigns a fundamental rating of 1 / 10 to EVGN. EVGN may be in some trouble as it scores bad on both profitability and health.
EVGN Financial Highlights
Over the last trailing twelve months EVGN reported a non-GAAP Earnings per Share(EPS) of -2.25. The EPS increased by 43.18% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -44.34% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
EVGN Forecast & Estimates
8 analysts have analysed EVGN and the average price target is 3.06 USD. This implies a price increase of 154.36% is expected in the next year compared to the current price of 1.203.
For the next year, analysts expect an EPS growth of 27.52% and a revenue growth -45.72% for EVGN